SEC Form 4 reporting owner

Bernstein Harold

Bernstein Harold has filed 39 Form 4 transactions reported between December 29, 2025 and September 4, 2026, as President, R&D & CMO of Maze Therapeutics, Inc..

Name as filed: Bernstein Harold

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$6.6M
23 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 4, 2026
transaction date

Roles and reported holdings

  • MAZEMaze Therapeutics, Inc.
    Dec 29, 2025 – Sep 4, 2026

    President, R&D & CMO

    Held directly0 sh as of Sep 4, 2026 · Form 4

    24 months: $6.6M sold

Transaction history

All 39 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 4, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct9,705$255K@ $26.22Form 4
Sep 3, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct59$2K@ $25.78Form 4
Sep 3, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct5,130$133K@ $26.01Form 4
Sep 2, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct625$17K@ $27.12Form 4
Sep 2, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct4,481$118K@ $26.38Form 4
Sep 1, 2026MAZEPresident, R&D & CMOOption exerciseCode M · direct20,000—Form 4
Sep 1, 2026MAZEPresident, R&D & CMOOption exerciseCode M · direct16,141$168K@ $10.42Form 4
Aug 13, 2026MAZEPresident, R&D & CMOOption exerciseCode M · direct16,142$168K@ $10.42Form 4
Jul 1, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct1,200$36K@ $30.34Form 4
Jul 1, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct13,409$400K@ $29.86Form 4
Jul 1, 2026MAZEPresident, R&D & CMOOption exerciseCode M · direct14,609$152K@ $10.42Form 4
Jun 1, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct1,600$42K@ $26.36Form 4
Jun 1, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct13,253$339K@ $25.57Form 4
Jun 1, 2026MAZEPresident, R&D & CMOOption exerciseCode M · direct14,853$155K@ $10.42Form 4
May 14, 2026MAZEPresident, R&D & CMOOption exerciseCode M · direct15,000$156K@ $10.42Form 4
Apr 1, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct300$9K@ $31.07Form 4
Apr 1, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct3,348$101K@ $30.06Form 4
Apr 1, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct11,352$332K@ $29.24Form 4
Apr 1, 2026MAZEPresident, R&D & CMOOption exerciseCode M · direct15,000$156K@ $10.42Form 4
Mar 20, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct5,044$252K@ $50.02Form 4
Mar 20, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct3,795$187K@ $49.32Form 4
Mar 20, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct6,161$297K@ $48.20Form 4
Mar 20, 2026MAZEPresident, R&D & CMOOption exerciseCode M · direct15,000$156K@ $10.42Form 4
Mar 10, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct348$18K@ $51.02Form 4
Mar 10, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct29,652$1.5M@ $50.45Form 4
Mar 10, 2026MAZEPresident, R&D & CMOOption exerciseCode M · direct30,000$313K@ $10.42Form 4
Mar 2, 2026MAZEPresident, R&D & CMOGrant or awardCode A · direct24,000—Form 4
Mar 2, 2026MAZEPresident, R&D & CMOGrant or awardCode A · direct48,000—Form 4
Feb 2, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct100$5K@ $47.23Form 4
Feb 2, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct5,936$275K@ $46.37Form 4
Feb 2, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct8,364$384K@ $45.89Form 4
Feb 2, 2026MAZEPresident, R&D & CMOOpen-market saleCode S · direct600$27K@ $44.20Form 4
Feb 2, 2026MAZEPresident, R&D & CMOOption exerciseCode M · direct15,000$156K@ $10.42Form 4
Jan 7, 2026MAZEPresident, R&D & CMOOption exerciseCode M · direct25,156$262K@ $10.42Form 4
Jan 5, 2026MAZEPresident, R&D & CMOOption exerciseCode M · direct412$4K@ $10.42Form 4
Jan 2, 2026MAZEPresident, R&D & CMOOption exerciseCode M · direct4,432$46K@ $10.42Form 4
Dec 29, 2025MAZEPresident, R&D & CMOOpen-market saleCode S · direct17,200$704K@ $40.93Form 4
Dec 29, 2025MAZEPresident, R&D & CMOOpen-market saleCode S · direct27,800$1.1M@ $40.34Form 4
Dec 29, 2025MAZEPresident, R&D & CMOOption exerciseCode M · direct45,000$469K@ $10.42Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.